GSA Capital Partners’s Viridian Therapeutics VRDN Stock Holding History

GSA Capital Partners’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$802K	Buy
2025 Q1	–	Sell
2024 Q4	$217K	Buy
2023 Q4	–	Sell
2023 Q3	$166K	Buy
2020 Q4	–	Sell
2020 Q3	$15K	Buy